Articles filed under 'CANCER'
Between 5 and 10 percent of breast cancer cases are hereditary, arising because the patient inherits from the father or mother a mutation in a gene that is susceptible to causing the illness. BRCA1 and BRCA2 have already been identified as two of the genes to be monitored. It is estimated that 30 percent of hereditary breast cancer cases are due to mutations in one of these two genes (which suggests, at the same time, that there are other genes involved, but exactly how is still unknown). In any case, few of the mutations found in BRCA1 and BRCA2 could be clearly identified as pathological. The fact is that the mutations found were numerous; their variation even depending on the population.
Continue Reading
March 1st, 2011
Obese women may avoid mammograms because of pain and women under 60 may avoid the test because they are too busy, according to a new study.
Continue Reading
March 1st, 2011
Former Fremonter writes articles, blogs and a book on fatherhoodFremont TribuneFive years ago, Higley, then 44, was diagnosed with early stage prostate cancer. "They caught it by accident. I had zero symptoms," he said, adding, "I was ex…
Continue Reading
March 1st, 2011
Researchers have discovered that resveratrol — a compound found in red wine — when combined with rapamycin can have a tumor-suppressing effect on breast cancer cells that are resistant to rapamycin alone. The research also indicates that the PTEN tumor-suppressing gene contributes to resveratrol’s anti-tumor effects in this treatment combination.
Continue Reading
February 28th, 2011
Ductal carcinoma in situ, or non-invasive breast cancer, is typically treated with either breast-conserving surgery — with or without follow-up radiation — or mastectomy. The treatment choice depends on clinical factors, the treating surgeon, and patient preferences. Long-term health outcomes (disease-free survival) depend on the treatments received. According to a new study, however, health outcomes also are associated with the treating surgeon.
Continue Reading
February 28th, 2011
Doctors are calling for women to receive more information about the pitfalls of breast cancer screening, as well as the benefits, after some women who received false-positive results faced serious anxiety and reduced quality of life for at least a year. The study of 385 women found that the 233 with false-positive results – where the mammogram is abnormal but no cancer is present – had to undergo more diagnostic procedures than women with breast cancer before they were given the all clear. And women who had a tendency to be anxious fared much worse if they received a false-positive – estimated to happen in 60% of abnormal mammograms – than if they were actually diagnosed with breast cancer.
Continue Reading
February 27th, 2011
Continue Reading
February 26th, 2011
|
This Week's 5 Smartest Stock MovesMotley FoolLater this year, Exelixis will begin testing its prostate cancer drug cabozantinib as a possible treatment for other types of cancer. Vertex's VX-770 received positive data from a drug trial, showing improved lung function in some patients with cystic …
and more »
|
Continue Reading
February 26th, 2011
Continue Reading
February 25th, 2011
|
Exelixis Shares Popped: What You Need to KnowMotley FoolMore importantly, and probably a bigger reason for the move, was the overview on prostate cancer drug cabozantinib that management provided in the earnings call. Now what: In short, the cabo information is nothing but great news. …
and more »
|
Continue Reading
February 25th, 2011
Next Posts
Previous Posts
